Global Medical Director, Vaccines (MD)
Pfizer New York, NY Remote 18 hours ago 11 applicants
Full-time · Mid-Senior level
10,001+ employees · Pharmaceutical Manufacturing
1 connection · 172 school alumni
See how you compare to 11 applicants. Try Premium for free
Actively recruiting
About the job
Global Medical Director, Vaccines, MD
Reporting to the Global Medical Director, the Global Medical Director will develop global medical content for the COVID-19 Vaccine Integrated Data Hub (IDH) which is a key strategic goal for Pfizer’s Vaccines Business Unit in 2022-2023. IDH is a medical-to-medical website with the objective to provide up-to-date clinical trial and real-world evidence from peer-reviewed publications for the COVID-19 vaccine. This initiative is sponsored by the Vaccines BU Chief Medical Officer.
The Global Medical Director will work collaboratively across the broader mRNA MDSCA team and key stakeholders (e.g. regional medical, country field medical, PHI, US field medical, US medical, medical information, etc.) to ensure global alignment and accuracy of medical content for IDH. The Global Medical Director will also provide Pfizer cross-functional partners with medical insights gained from the IDH site data analysis, search querying, etc. Finally, the Global Medical Director will maintain IDH data recency to publications, preprints and country surveillance reports.
Role Responsibilities
Collaborate cross functionally with field medical, USMI, PHI, legal, commercial, compliance and other cross functional colleagues to author medical-to-medical content, oversee selection of studies and summarize for IDH MRC review
Proactively seek alignment with medical, clinical, safety and other scientific stakeholders to ensure IDH content is aligned across the organization
Be a Pfizer expert on organizing current information on COVID-19 vaccines authorizations and restrictions across countries
Serve as a reliable expert source of scientific knowledge for clinical, disease state, real-world evidence, surveillance and epidemiologic data
Communicate IDH vision, goals and objectives to internal and external audiences as appropriate
Direct agency/vendors’ search, extraction, data visualization, and personally lead alignment related activities
Support internal medical training curriculum for IDH site launches and enhancements
Basic Qualifications
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
MD/DO or equivalent professional degrees
7 + years of experience in either the pharmaceutical industry, academic centers, clinical practice or a combination of these
Knowledge of pharmaceutical space in Vaccines TA
Preferred Qualifications
Experience in Medical Affairs is essential
Expertise or experience in vaccines is desirable
Strong interpersonal skills and excellent verbal communication and presentation skills.
Proven ability to facilitate open discussion and debate among key stakeholders and build internal and external relationships
Well-organized with the ability to be flexible, prioritize multiple demands, and effectively lead in a matrix organization
Other job details:
Last Date to Apply for Job : 03/16/2022
Additional Location Information: US - remote
Eligible for Employee Referral Bonus
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Medical
What if the COVID-19 vaccines are not really vaccines?
Evidence has come to light strongly indicating that the Moderna and Pfizer COVID-19 vaccines are not really “vaccines” in the medical and legal sense of the word, but rather “experimental gene therapies.” If proven true, the significance and legal ramifications of this allegation are profound.
This article summarizes a presentation by Dr. David Martin, a national intelligence analyst and founder of IQ100 Index, a developer of linguistic genomics, and molecular biologist Dr. Judy Mikovits.
In the presentation, Dr. Martin states, “You cannot have a vaccine that doesn’t claim to result in either immunity or blocking transmission.” He goes on to say, “By their own patents and reference material, neither Pfizer nor Moderna claims this. Rather, they only classify their products as ‘gene therapy.’”
Dr. Martin states the Moderna and Pfizer products “do not prevent you from getting the COVID-19 infection, nor do they prevent its spread. They are really experimental gene therapies — unlike real vaccines, which use an antigen of the disease you’re trying to prevent, the Moderna and Pfizer injections contain synthetic RNA fragments encapsulated in a nanolipid carrier compound, the sole purpose of which is to lessen clinical symptoms associated with the S-1 spike protein, not the actual virus.”
If indeed Moderna and Pfizer corporations are misrepresenting their experimental gene therapies as bona fide vaccines, Dr. Martin states that “the legal ramifications of this deception are immense — from a legal view, both Moderna and Pfizer qualify as using illegal deceptive practices by making medical claims without clinic trial proof of immunity and transmission blocking. The U.S. Federal Trade Commission Act, 15 U.S. Code, Section 41, outlaws such deceptive practices.”
During the presentation, various entities and individuals were identified as supporters of the above alleged deception, including the U.S. Centers for Disease Control and Prevention, a professor of microbiology and immunology at the University of North Carolina, and other individuals.
Why call an experimental gene therapy product a “vaccine”? Dr. Martin believes that there are two basic reasons: 1) to circumvent liability for damages, and 2) if the products were called gene therapy or a similar label, most people would wisely refuse to use them.
Regarding avoiding liability for damages, as long as the U.S. is under a state of emergency, things like COVID-19 “vaccines” are allowed under emergency use authorization. As long as the emergency use authorization is in effect, the makers of these “vaccines” are not financially liable for any damages that comes from their use. However, Dr Martin states that “there is no liability shield for a medical emergency countermeasure that is gene therapy.” In fact, if the documentation Pfizer and Moderna provided the Federal Drug Administration for emergency use authorization can be proven fraudulent, then there is no legal protection.
Given the above, a multitude of multi-million-dollar lawsuits are possible, if not probable, against the two pharmaceutical companies by parties who have been “injured” in one way or another by Moderna and Pfizer inoculations. Depending on the evidence produced, criminal indictments may also be a possibility.
What needs to happen next? Dr. Martin urges citizens to contact their state attorney, governor, representatives, and anyone else who might be in a position to take action to address and correct what he calls a tremendous fraud on the American people. He hopes his presentation will be viewed and acted upon by officials with the authority to thoroughly investigate his findings.
He states, “Defense contractors are violating FTC law, and gene therapy companies — not vaccine manufacturers — are conducting experimental trials under deceptive medical practices. They’re making claims of being ‘vaccines’ without clinical proof, and must be held accountable for their deceptive marketing and medical practices.”
The need for accountability extends to anyone who promoted the use of the Moderna and Pfizer products while having full knowledge that they were not bona fide vaccines as described herein.
Dr. Martin states, “World governments and global and national health organizations are all complicit in this illegal deception and must be held accountable.”
In conclusion, Dr. Martin makes a most sobering comment: “These injections are not vaccines. They do not prevent infection, they do not render you immune, and they do not prevent transmission of the disease. Instead, they alter your genetic coding.”
Given the above, perhaps it is time for several state attorneys general to band together and thoroughly investigate the activities of Moderna, Pfizer, and various individuals in this matter. This could develop into a similar cooperative multi-state effort reminiscent of the 1998 Big Tobacco lawsuit. In this action, 52 state and territory attorneys general ultimately signed a Master Settlement Agreement with the four largest tobacco companies in the U.S. to settle dozens of state lawsuits brought to recover billions of dollars in health care costs associated with treating smoking-related illnesses.
Paul S. Gardiner is a retired Army officer, Vietnam veteran, and lover of America. He is a graduate of the University of North Carolina, University of Alabama, and the United States Army War College. He is hopeful that the truth will eventually emerge about the Moderna and Pfizer inoculation products as well as truth about statements made by various high-ranking officials promoting their use.
Image: qimono via Pixabay, Pixabay License.